BioSpace News Archive

Foot and Ankle Plating System Market: Total ankle replacements are expected to hold the leading share of the segment during the forecast period

In case of injury, trauma, or defect in the lower extremities of the body, i.e. the feet and ankles, special plates and screws are available for use to rectify and reconstruct them.

September 2, 2020
·
4 min read
Prostate Cancer Therapeutics Market: Product Differentiation to Create Fructuous Opportunities

Transparency Market Research has published a new report on the prostate cancer therapeutics market for the forecast period of 2019–2027.

September 2, 2020
·
7 min read
Empty Capsules Market: Rapid Expansion of Nutraceutical and Pharmaceutical Industry is a key driving factor

Drug capsules made from gelatin act as superior carriers of both, hydrophilic and lipophilic drugs, and render them protection from degradation.

September 2, 2020
·
6 min read
Deals

Miracor Medical Raises 24M€

Miracor Medical SA has announced the closing of a 24M€ Series-E round of financing. The round was led by a new corporate strategic investor joined by co-investor Yonghua.

September 2, 2020
·
3 min read
Venipuncture Procedure Analysis Market Growth is Majorly Driven by Increasing Incidence of Various Chronic Diseases

The significant rise in the prevalent of chronic diseases across the world, including the increasing incidence of cardiovascular diseases, which need early detection, is influencing the global market for venipuncture procedure analysis significantly.

September 2, 2020
·
6 min read
Inhalation and Nasal Spray Generic Drugs Market: Low cost involved with generic prescription drugs to Drive Market

According to Transparency Market Research’s latest report on the global inhalation and nasal spray generic drugs market for the historical period 2017–2018 and forecast period 2019–2027, increasing prevalence of asthma and COPD disorders, and burgeoning demand for cost-effective generic drugs are projected to drive the global inhalation and nasal spray generic drugs market during the forecast period

September 2, 2020
·
4 min read
Policy

Mesoblast Receives Ethics Approval to Treat COVID-19 Patients in Australia

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has received ethics approval to include Australian hospitals in the Phase 3 randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with acute respiratory distress syndrome.

September 2, 2020
·
6 min read
BioMidwest

Central Ohio Urology Group First in Region to Offer Micro-Ultrasound for Most Accurate Prostate Cancer Diagnosis

Central Ohio Urology Group, one of the largest urology practices in Central Ohio and the Columbus MSA, has acquired ExactVu™ Micro-Ultrasound, specifically designed to aid in the diagnosis of prostate cancer using real-time imaging for biopsy guidance.

September 2, 2020
·
2 min read
Genetown

Imara to Present at Upcoming Investor ConferencesCiti 15th Annual BioPharma Virtual Conference and Morgan Stanley 18th Annual Global Healthcare Conference

Imara Inc. announced that the Company will participate in the following upcoming virtual investor conferences in September

September 2, 2020
·
1 min read
Pharm Country

New Scientific Data at the ESMO Virtual Congress 2020 Reflect Merck’s Commitment to Advancing Cancer Research and Care

Pivotal Studies for KEYTRUDA® (pembrolizumab) in Esophageal Cancer (KEYNOTE-590) and LYNPARZA® (olaparib) in Prostate Cancer (PROfound) Selected for ESMO Presidential Symposium Sessions

September 2, 2020
·
69 min read